ASX:ELX

Stock Analysis Report

Ellex Medical Lasers

Executive Summary

Ellex Medical Lasers Limited designs, manufactures, distributes, and sells lasers and ultrasound systems for ophthalmologists to diagnose and treat eye diseases.

Snowflake

Fundamentals

Excellent balance sheet with reasonable growth potential.


Similar Companies

Share Price & News

How has Ellex Medical Lasers's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-4.3%

ELX

-1.8%

AU Medical Equipment

0.1%

AU Market


1 Year Return

-11.9%

ELX

29.8%

AU Medical Equipment

11.9%

AU Market

Return vs Industry: ELX underperformed the Australian Medical Equipment industry which returned 29.8% over the past year.

Return vs Market: ELX underperformed the Australian Market which returned 11.9% over the past year.


Shareholder returns

ELXIndustryMarket
7 Day-4.3%-1.8%0.1%
30 Day-2.6%-0.06%-1.1%
90 Day-7.5%-0.9%-1.4%
1 Year-11.9%-11.9%31.9%29.8%18.5%11.9%
3 Year-56.0%-56.0%50.0%43.4%36.4%18.1%
5 Year98.2%98.2%142.8%122.9%50.9%16.7%

Price Volatility Vs. Market

How volatile is Ellex Medical Lasers's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Ellex Medical Lasers undervalued compared to its fair value and its price relative to the market?

1.16x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate ELX's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate ELX's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: ELX is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: ELX is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ELX's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ELX is good value based on its PB Ratio (1.2x) compared to the AU Medical Equipment industry average (4.7x).


Next Steps

Future Growth

How is Ellex Medical Lasers forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

77.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ELX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Earnings vs Market: ELX is forecast to become profitable over the next 3 year, which is considered above average market growth.

High Growth Earnings: ELX's loss is forecast to worsen by 0% next year.

Revenue vs Market: ELX's revenue (10.9% per year) is forecast to grow faster than the Australian market (3.6% per year).

High Growth Revenue: ELX's revenue (10.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ELX's Return on Equity is forecast to be low in 3 years time (5.8%).


Next Steps

Past Performance

How has Ellex Medical Lasers performed over the past 5 years?

-60.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: ELX is unprofitable, and losses have increased over the past 5 years at a rate of -60.9% per year.

Accelerating Growth: Unable to compare ELX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ELX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (29.5%).


Return on Equity

High ROE: ELX has a negative Return on Equity (-8.39%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: ELX is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: ELX is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Ellex Medical Lasers's financial position?


Financial Position Analysis

Short Term Liabilities: ELX's short term assets (A$57.7M) exceeds its short term liabilities (A$29.3M)

Long Term Liabilities: ELX's short term assets (57.7M) exceeds its long term liabilities (1.8M)


Debt to Equity History and Analysis

Debt Level: ELX's debt to equity ratio (21.7%) is considered satisfactory

Reducing Debt: ELX's debt to equity ratio has increased from 15.5% to 21.7% over the past 5 years.


Balance Sheet

Inventory Level: ELX has a high level of physical assets or inventory.

Debt Coverage by Assets: ELX's debt is covered by short term assets (assets are 3.870990x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ELX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: ELX has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 4.7% each year


Next Steps

Dividend

What is Ellex Medical Lasers's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.4%markettop25%5.6%industryaverage1.6%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate ELX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ELX's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if ELX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ELX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ELX's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

What is the CEO of Ellex Medical Lasers's salary, the management and board of directors tenure and is there insider trading?

0.8yrs

Average management tenure


CEO

Maria Maieli (51yo)

0.3yrs

Tenure

0

Ms. Maria Maieli, CPA, MPACC, AGIA, has been the Interim Chief Executive Officer of Ellex Medical Lasers Limited since July 19, 2019 and has been its Chief Financial Officer since May 2011. Ms. Maieli serv ...


Management Age and Tenure

0.8yrs

Average Tenure

59yo

Average Age

Experienced Management: ELX's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.


Board Age and Tenure

8.7yrs

Average Tenure

58.5yo

Average Age

Experienced Board: ELX's board of directors are considered experienced (8.7 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyAU$309,31819 Aug 19
Australian Ethical Investment Ltd
EntityCompany
Shares560,365
Max PriceAU$0.59
BuyAU$1,339,66819 Aug 19
Jencay Capital Pty Ltd
EntityCompany
Shares2,322,013
Max PriceAU$0.58
BuyAU$3,331,76609 May 19
Australian Ethical Investment Ltd
EntityCompany
Shares4,568,634
Max PriceAU$0.73
BuyAU$1,004,36105 Nov 18
Investors Mutual Limited
EntityCompany
Shares1,450,000
Max PriceAU$0.72

Ownership Breakdown


Management Team

  • Joaquin Wolff (61yo)

    President of Ellex iTrack

    • Tenure: 1.3yrs
  • Victor Previn (61yo)

    Founder & Executive Chairman

    • Tenure: 14.3yrs
    • Compensation: AU$271.69k
  • Bill Swaim

    President of Laserex IS Ellex (USA)

    • Tenure: 0yrs
    • Compensation: AU$314.07k
  • Tom Spurling (57yo)

    Consultant

    • Tenure: 0.5yrs
    • Compensation: AU$447.89k
  • Tom Duthy

    Head of Investor Relations and Corporate Development

    • Tenure: 0yrs
  • Maria Maieli (51yo)

    Interim CEO & CFO

    • Tenure: 0.3yrs
  • Kate Hunt

    Corporate Communications Manager

    • Tenure: 0yrs
  • Mike Southard

    Executive Director

    • Tenure: 1.3yrs
    • Compensation: AU$163.38k
  • David Lubeck

    Chief Medical Officer

    • Tenure: 1yrs
  • Kimberley Menzies

    Group Financial Controller & Company Secretary

    • Tenure: 0.3yrs

Board Members

  • Victor Previn (61yo)

    Founder & Executive Chairman

    • Tenure: 14.3yrs
    • Compensation: AU$271.69k
  • Alex Sundich (55yo)

    Non-Executive Director

    • Tenure: 14.3yrs
    • Compensation: AU$60.28k
  • Rahmon Coupe (56yo)

    Independent Director

    • Tenure: 6.4yrs
    • Compensation: AU$60.23k
  • Giuseppe Canala (72yo)

    Non-Executive Director

    • Tenure: 11yrs
    • Compensation: AU$65.75k
  • Mike Mangano

    Independent Director

    • Tenure: 1.3yrs
    • Compensation: AU$70.42k
  • Mike Southard

    Executive Director

    • Tenure: 1.3yrs
    • Compensation: AU$163.38k

Company Information

Ellex Medical Lasers Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Ellex Medical Lasers Limited
  • Ticker: ELX
  • Exchange: ASX
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: AU$78.981m
  • Shares outstanding: 143.60m
  • Website: https://www.ellex.com

Number of Employees


Location

  • Ellex Medical Lasers Limited
  • 3 Second Avenue
  • Mawson Lakes
  • South Australia
  • 5095
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ELXASX (Australian Securities Exchange)YesOrdinary SharesAUAUDJan 1992
ELXM.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDJan 1992
ELXCHIA (Chi-X Australia)YesOrdinary SharesAUAUDJan 1992
ELXM.YOTCPK (Pink Sheets LLC)SPONSORED ADSUSUSDNov 2018

Biography

Ellex Medical Lasers Limited designs, manufactures, distributes, and sells lasers and ultrasound systems for ophthalmologists to diagnose and treat eye diseases. It operates through three segments: Laser a ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/23 10:31
End of Day Share Price2019/10/23 00:00
Earnings2019/06/30
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.